# Bioventus divests Advanced Rehabilitation business to Accelmed Partners for $45M

Bioventus has signed a definitive agreement to sell its Advanced Rehabilitation business (Bioness) to Accelmed Partners for total cash consideration of $45 million, including $25 million at close and up to $20 million in earn-outs.

- Type: Acquisition
- Announced: 2024-10-01
- Where: United States
- Value: $45.0M
- Status: announced
- Products: advanced rehabilitation products for stroke and neuromuscular conditions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bioventus Inc.](https://endata.com/companies/54140.md)
- [Bioness Inc.](https://endata.com/companies/54141.md) (target)
- [Accelmed Partners](https://endata.com/companies/80187.md) (acquirer)

## Sources

- [business.woonsocketcall.com](https://business.woonsocketcall.com/observerreporter/article/gnwcq-2024-10-1-bioventus-announces-divestiture-of-its-advanced-rehabilitation-business-to-accelmed-partners), 2024-10-01: "This agreement reflects our deep respect for the Advanced Rehabilitation business and the many patients who benefit from its life-changing technology."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.